124 related articles for article (PubMed ID: 26596282)
21. Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments.
Chuang YP; Chang YP; Tu LH
Protein Sci; 2023 Aug; 32(8):e4711. PubMed ID: 37354016
[TBL] [Abstract][Full Text] [Related]
22. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
23. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
Paul S; Paul S
Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
[TBL] [Abstract][Full Text] [Related]
24. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.
Hattersley G; Chambers TJ
Endocrinology; 1989 Sep; 125(3):1606-12. PubMed ID: 2547591
[TBL] [Abstract][Full Text] [Related]
26. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
[TBL] [Abstract][Full Text] [Related]
27. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG.
Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A
J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484
[TBL] [Abstract][Full Text] [Related]
28. Calcium signaling in osteoclast differentiation and bone resorption.
Kajiya H
Adv Exp Med Biol; 2012; 740():917-32. PubMed ID: 22453976
[TBL] [Abstract][Full Text] [Related]
29. Antithetic effects of ryanodine and ruthenium red on osteoclast-mediated bone resorption and intracellular calcium concentrations.
Ritchie CK; Strei TA; Maercklein PB; Fitzpatrick LA
J Cell Biochem; 1995 Oct; 59(2):281-9. PubMed ID: 8904321
[TBL] [Abstract][Full Text] [Related]
30. Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro.
D'Souza SM; MacIntyre I; Girgis SI; Mundy GR
Endocrinology; 1986 Jul; 119(1):58-61. PubMed ID: 3487444
[TBL] [Abstract][Full Text] [Related]
31. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro.
Hahn TJ; Scharp CR; Richardson CA; Halstead LR; Kahn AJ; Teitelbaum SL
J Clin Invest; 1978 Aug; 62(2):406-14. PubMed ID: 209062
[TBL] [Abstract][Full Text] [Related]
32. Molecular physiology and pharmacology of calcitonin.
Huang CL; Sun L; Moonga BS; Zaidi M
Cell Mol Biol (Noisy-le-grand); 2006 Sep; 52(3):33-43. PubMed ID: 17535752
[TBL] [Abstract][Full Text] [Related]
33. Effect of eel calcitonin glycosylation on incorporation and channel formation in planar phospholipid membranes.
Meleleo D; Micelli S; Toma K; Haneda K; Gallucci E
Peptides; 2006 Apr; 27(4):805-11. PubMed ID: 16289470
[TBL] [Abstract][Full Text] [Related]
34. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
Hall TJ
Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
[TBL] [Abstract][Full Text] [Related]
35. The relationship between calcium accumulation in osteoclast mitochondrial granules and bone resorption.
Kawahara I; Koide M; Tadokoro O; Udagawa N; Nakamura H; Takahashi N; Ozawa H
Bone; 2009 Nov; 45(5):980-6. PubMed ID: 19631304
[TBL] [Abstract][Full Text] [Related]
36. Enhanced physical stability of human calcitonin after methionine oxidation.
Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
Eur J Pharm Biopharm; 2011 Jun; 78(2):229-38. PubMed ID: 21296150
[TBL] [Abstract][Full Text] [Related]
37. Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations.
Ritchie CK; Maercklein PB; Fitzpatrick LA
Endocrinology; 1994 Sep; 135(3):996-1003. PubMed ID: 8070395
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the calcium pump by human parathyroid hormone-(1-34) and human calcitonin in liver plasma membranes.
McKenzie RC; Lotersztajn S; Pavoine C; Pecker F; Epand RM; Orlowski RC
Biochem J; 1990 Mar; 266(3):817-22. PubMed ID: 2158300
[TBL] [Abstract][Full Text] [Related]
39. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae.
Sone T; Kohno H; Kikuchi H; Ikeda T; Kasai R; Kikuchi Y; Takeuchi R; Konishi J; Shigeno C
Endocrinology; 1992 Dec; 131(6):2742-6. PubMed ID: 1306984
[TBL] [Abstract][Full Text] [Related]
40. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
Granholm S; Henning P; Lerner UH
J Cell Biochem; 2011 Nov; 112(11):3300-12. PubMed ID: 21748786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
